Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Non-Current Assets (2018 - 2025)

Inventiva (IVEVF) posted Non-Current Assets of $5.9 million for Q4 2025, down 65.6% on a QoQ basis from $17.1 million in Q2 2025, and down 26.34% year-over-year from $8.0 million in Q4 2024.

Analysis

Inventiva (IVEVF) Non-Current Assets (2018 - 2025) Analysis & Trends

Inventiva has reported Non-Current Assets for 8 years, with the latest figure at $5.9 million in Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 26.34% year-over-year to $5.9 million in Q4 2025; TTM through Dec 2025 was $5.9 million, a 26.34% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 26.34% from the prior year.
  • Non-Current Assets was $5.9 million for Q4 2025 at Inventiva, down from $17.1 million in the prior quarter.
  • The five-year high for Non-Current Assets was $23.0 million in Q4 2023, with the low at $5.9 million in Q4 2025.
  • Average Non-Current Assets over 5 years is $12.3 million, with a median of $9.0 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Assets soared 134.25% in 2023, then sank 65.35% in 2024.
  • Over 5 years, Non-Current Assets stood at $7.3 million in 2021, then soared by 33.9% to $9.8 million in 2022, then jumped by 134.25% to $23.0 million in 2023, then tumbled by 65.35% to $8.0 million in 2024, then fell by 26.34% to $5.9 million in 2025.
  • The last three Non-Current Assets figures came in at $5.9 million (Q4 2025), $17.1 million (Q2 2025), and $8.0 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn 141.29 Bn
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn 101.45 Bn
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn 94.68 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 159.77 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 113.37 Bn
7 Revolution Medicines 44.19 Bn 44.19 Bn - 294.93 Mn
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn 1.85 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 3.74 Bn
10 Inventiva 693.72 Mn 693.72 Mn - 5.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.87 Mn
Jun 30, 2025 17.06 Mn
Dec 31, 2024 7.97 Mn
Jun 30, 2024 18.54 Mn
Dec 31, 2023 22.99 Mn
Jun 30, 2023 20.09 Mn
Dec 31, 2022 9.82 Mn
Jun 30, 2022 9.03 Mn
Dec 31, 2021 7.33 Mn
Jun 30, 2021 8.89 Mn
Mar 31, 2021 8.21 Mn
Dec 31, 2020 7.06 Mn
Jun 30, 2020 9.42 Mn
Dec 31, 2019 8.95 Mn
Dec 31, 2018 9.33 Mn